JAG2 and colorectal cancer: Mechanistic investigations indicated that the Notch ligand JAG2 was a direct target of tRF/miR-1280 binding and that tRF/miR-1280 inhibited colorectal cancer growth and metastasis by suppressing the Notch signaling pathway that supported the CSC phenotype (166).